1978
DOI: 10.1038/273609a0
|View full text |Cite
|
Sign up to set email alerts
|

The pathology, pathobiology and pathogenesis of schistosomiasis

Abstract: Although the general pathology of schistosomiasis has been well understood for more than 70 years, it is only recently that it has been possible to analyse the disease at the molecular level and to understand the relationship between the number of parasites in an infected individual and the appearance of overt disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
61
0
3

Year Published

1981
1981
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 94 publications
(65 citation statements)
references
References 33 publications
1
61
0
3
Order By: Relevance
“…The prevalence of pathological changes is not always associated with egg output or laboratory tests; it is possible that disease is present, but that Schistosoma mansoni eggs are not being excreted and remain trapped in fibrous lesions 12 . Previous studies on experimental animals have estimated that 50% of the eggs are retained in tissues, especially in the liver 33 .…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of pathological changes is not always associated with egg output or laboratory tests; it is possible that disease is present, but that Schistosoma mansoni eggs are not being excreted and remain trapped in fibrous lesions 12 . Previous studies on experimental animals have estimated that 50% of the eggs are retained in tissues, especially in the liver 33 .…”
Section: Discussionmentioning
confidence: 99%
“…Over time, morbidity may progress from subtle manifestations such as anemia, to more severe, debilitating, and irreversible conditions such as growth stunting, impaired cognitive development, increased susceptibility to co-infection, decreased quality of life, exercise intolerance, infertility, portal hypertension, and liver failure. [9][10][11][12][13][14][15] The key determinants of morbidity progression are repeated infection, intensity of infection, and duration of infection. 16 Currently, the WHO strategy for schistosomiasis control relies on mass-drug administration (MDA) of praziquantel, 17 which is effective in reducing disease-associated morbidity.…”
Section: Introductionmentioning
confidence: 99%
“…After that, they pair up and shed eggs, increasing the chance of invasion into the CNS. Warren et al [29] have studied the schistosomiasis epidemiology, pathology and autopsy. They report that there are connections between egg burden and the number of worms in the host.…”
Section: Spinal Cord Schistosomiasis and The Pathway Of Vertebral Batmentioning
confidence: 99%